Hubei Biocause Pharmaceutical Company Description

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China.

It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride.

It exports its products to approximately 85 countries, including the United States, the European Union, and internationally.

The company is based in Jingmen, China.

Hubei Biocause Pharmaceutical Co., Ltd.

Country	China
Industry	Insurance - Life
Sector	Financials
Employees	1,765
CEO	Wenxia Zhou

Contact Details

Address: 122-132 Yangwan Road Jingmen, 448000 China
Phone	86 27 6565 1730
Website	biocause.com

Stock Details

Ticker Symbol	000627
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE000000F48
SIC Code	2800

Key Executives

Name	Position
Wenxia Zhou	Vice Chairman and GM
Dali Chen	Chief Financial Officer and Director
Fei Long	Secretary of the Board and Non-Independent Director